Brief: PharmaSGP 9-Month Adjusted EBIT Up At EUR 15.4 Mln

PharmaSGP Holding SE

30/11/2020 06:32

Nov 30 (Reuters) - PHARMASGP HOLDING SE  PSGG.DE :
    * GROUP REVENUES RAISED BY 6.2% TO EUR 48.6 MILLION IN FIRST
NINE
MONTHS OF 2020
    * ADJUSTMENT OF 2020 FORECAST DUE TO IMPAIRED SALES
PERFORMANCE
AND DISTRIBUTION IN Q4
    * 9-MONTH ADJUSTED EBIT MARGIN INCREASED TO 31.8%
    * NOW EXPECTS FY REVENUE GROWTH AND AN ADJUSTED EBIT MARGIN
BELOW
PREVIOUS FORECAST
    * NOT YET POSSIBLE TO MAKE A RELIABLE ESTIMATE OF REVENUES
AND
EARNINGS DEVELOPMENT FOR Q4 AND THUS ALSO FOR CONCRETE BUSINESS
DEVELOPMENT FOR FULL YEAR 2020
    * 9-MONTH EBIT, AFTER ADJUSTING FOR ONE-TIME EFFECTS^ 1  1 ,
GREW
FASTER THAN REVENUES, RISING BY 8.0% TO EUR 15.4 MILLION (9M
2019: EUR 14.3 MILLION)

Source text for Eikon:  ID:nEQ9RSp96a 
Further company coverage:  PSGG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))